Treace Medical Concepts (TMCI) Enterprise Value (2020 - 2026)
Treace Medical Concepts (TMCI) posted Enterprise Value of -$51.9 million for Q1 2026, down 7.21% on a QoQ basis from -$48.4 million in Q4 2025, and up 31.85% year-over-year from -$39.3 million in Q1 2025.
Treace Medical Concepts (TMCI) Enterprise Value (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Enterprise Value history runs 7 years deep, the most recent figure standing at -$51.9 million for Q1 2026.
- Quarterly Enterprise Value rose 31.85% year-over-year to -$51.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$51.9 million (up 31.85% YoY) and the FY2025 annual result came in at -$48.4 million, up 36.09% from the prior year.
- Enterprise Value was -$51.9 million for Q1 2026 at Treace Medical Concepts, down from -$48.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$48.4 million in Q4 2025 and bottomed at -$170.7 million in Q1 2023.
- A 5-year average of -$94.0 million and a median of -$88.9 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value tumbled 507.25% — and 2024, when it soared 38.57%.
- Treace Medical Concepts' Enterprise Value stood at -$81.3 million in 2022, then plunged by 51.62% to -$123.2 million in 2023, then surged by 38.57% to -$75.7 million in 2024, then surged by 36.09% to -$48.4 million in 2025, then dropped by 7.21% to -$51.9 million in 2026.
- Business Quant data shows TMCI's Enterprise Value at -$51.9 million in Q1 2026, -$48.4 million in Q4 2025, and -$57.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | -51.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.85 Mn |
| Dec 31, 2025 | -48.37 Mn |
| Sep 30, 2025 | -57.42 Mn |
| Jun 30, 2025 | -69.29 Mn |
| Mar 31, 2025 | -76.09 Mn |
| Dec 31, 2024 | -75.68 Mn |
| Sep 30, 2024 | -82.80 Mn |
| Jun 30, 2024 | -95.05 Mn |
| Mar 31, 2024 | -110.01 Mn |
| Dec 31, 2023 | -123.20 Mn |
| Sep 30, 2023 | -122.16 Mn |
| Jun 30, 2023 | -139.48 Mn |
| Mar 31, 2023 | -170.66 Mn |
| Dec 31, 2022 | -81.25 Mn |
| Jun 30, 2022 | -101.53 Mn |
| Mar 31, 2022 | -98.48 Mn |
| Dec 31, 2021 | -105.83 Mn |
| Sep 30, 2021 | -109.46 Mn |
| Jun 30, 2021 | -119.62 Mn |
| Mar 31, 2021 | -16.22 Mn |